14.93
price up icon5.59%   0.79
after-market Handel nachbörslich: 14.93
loading
Schlusskurs vom Vortag:
$14.14
Offen:
$13.55
24-Stunden-Volumen:
1.53M
Relative Volume:
2.38
Marktkapitalisierung:
$1.77B
Einnahmen:
$628.25M
Nettoeinkommen (Verlust:
$-78.55M
KGV:
-19.39
EPS:
-0.77
Netto-Cashflow:
$-29.73M
1W Leistung:
+10.43%
1M Leistung:
+7.10%
6M Leistung:
-2.42%
1J Leistung:
-2.23%
1-Tages-Spanne:
Value
$13.35
$15.08
1-Wochen-Bereich:
Value
$13.21
$15.08
52-Wochen-Spanne:
Value
$12.77
$21.22

Neogenomics Inc Stock (NEO) Company Profile

Name
Firmenname
Neogenomics Inc
Name
Telefon
(239) 768-0600
Name
Adresse
9490 NEOGENOMICS WAY, FORT MYERS, FL
Name
Mitarbeiter
2,100
Name
Twitter
@NeoGenomics
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
NEO's Discussions on Twitter

Neogenomics Inc Stock (NEO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-01 Fortgesetzt Craig Hallum Buy
2023-12-29 Bestätigt BTIG Research Buy
2023-08-21 Hochstufung Stephens Equal-Weight → Overweight
2023-05-16 Herabstufung Raymond James Outperform → Mkt Perform
2023-05-09 Hochstufung BTIG Research Neutral → Buy
2023-02-24 Hochstufung The Benchmark Company Hold → Buy
2023-02-01 Hochstufung Needham Hold → Buy
2022-08-26 Herabstufung The Benchmark Company Buy → Hold
2022-08-22 Herabstufung Needham Buy → Hold
2022-06-03 Eingeleitet Piper Sandler Overweight
2022-03-29 Herabstufung BofA Securities Buy → Neutral
2022-03-29 Herabstufung Stephens Overweight → Equal-Weight
2022-01-18 Fortgesetzt Stephens Overweight
2021-12-16 Eingeleitet Cowen Outperform
2021-11-05 Herabstufung Morgan Stanley Overweight → Equal-Weight
2021-10-14 Hochstufung Raymond James Mkt Perform → Outperform
2021-06-03 Eingeleitet Goldman Buy
2021-02-25 Fortgesetzt Needham Buy
2021-02-25 Herabstufung Raymond James Outperform → Mkt Perform
2021-01-28 Eingeleitet Truist Buy
2020-12-11 Fortgesetzt BTIG Research Buy
2020-10-28 Bestätigt Needham Buy
2020-09-09 Eingeleitet Morgan Stanley Overweight
2020-08-28 Eingeleitet Guggenheim Buy
2020-07-29 Bestätigt Needham Buy
2020-06-25 Eingeleitet BofA/Merrill Buy
2020-04-21 Fortgesetzt Stephens Overweight
2020-03-02 Fortgesetzt Craig Hallum Buy
2020-02-28 Hochstufung First Analysis Sec Outperform → Strong Buy
2020-01-23 Herabstufung First Analysis Sec Strong Buy → Outperform
2019-10-30 Bestätigt Needham Buy
2019-05-01 Bestätigt Needham Buy
2019-03-29 Bestätigt Needham Buy
2019-01-03 Eingeleitet Needham Buy
2018-10-24 Hochstufung First Analysis Sec Outperform → Strong Buy
2018-08-21 Eingeleitet Leerink Partners Outperform
2018-05-02 Herabstufung First Analysis Sec Overweight → Equal-Weight
2017-09-11 Herabstufung BTIG Research Buy → Neutral
2017-08-24 Eingeleitet Gabelli & Co Buy
2016-12-15 Eingeleitet Cantor Fitzgerald Overweight
Alle ansehen

Neogenomics Inc Aktie (NEO) Neueste Nachrichten

pulisher
10:43 AM

NeoGenomics: Q3 Earnings Snapshot - The Washington Post

10:43 AM
pulisher
10:00 AM

NeoGenomics (NEO) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance

10:00 AM
pulisher
07:00 AM

NeoGenomics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

07:00 AM
pulisher
05:42 AM

NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

05:42 AM
pulisher
Nov 03, 2024

Emerald Mutual Fund Advisers Trust Sells 314,330 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Nov 03, 2024
pulisher
Nov 03, 2024

Allspring Global Investments Holdings LLC Reduces Stake in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

Blue Trust Inc. Boosts Stake in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

Nov 02, 2024
pulisher
Oct 29, 2024

NeoGenomics (NEO) to Release Earnings on Tuesday - MarketBeat

Oct 29, 2024
pulisher
Oct 23, 2024

NeoGenomics gains conditional approval for solid tumour assays in New York - Medical Device Network

Oct 23, 2024
pulisher
Oct 22, 2024

NeoGenomics NGS tests gain New York State approval - Investing.com

Oct 22, 2024
pulisher
Oct 22, 2024

NEONeoGenomics, Inc. Latest Stock News & Market Updates - StockTitan

Oct 22, 2024
pulisher
Oct 22, 2024

NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test - Business Wire

Oct 22, 2024
pulisher
Oct 17, 2024

Truist Financial Corp Sells 4,699 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

Oct 17, 2024
pulisher
Oct 16, 2024

NeoGenomics (NASDAQ:NEO) Shares Down 2.5%Should You Sell? - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Is NeoGenomics (NASDAQ:NEO) A Risky Investment? - Simply Wall St

Oct 16, 2024
pulisher
Oct 15, 2024

Neogenomics Inc. (NEO) gets rating Resumed from Craig Hallum - Knox Daily

Oct 15, 2024
pulisher
Oct 15, 2024

NeoGenomics to Report Third Quarter 2024 Financial Results on Nov. 5, 2024 - BioSpace

Oct 15, 2024
pulisher
Oct 15, 2024

Analytical Lens: Exploring Neogenomics Inc. (NEO)’s Financial Story Through Ratios - The Dwinnex

Oct 15, 2024
pulisher
Oct 14, 2024

Check out these key findings about Neogenomics Inc. (NEO) - SETE News

Oct 14, 2024
pulisher
Oct 13, 2024

Renaissance Technologies LLC Cuts Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Oct 13, 2024
pulisher
Oct 12, 2024

(NEO) Technical Data - Stock Traders Daily

Oct 12, 2024
pulisher
Oct 11, 2024

Breast Cancer Liquid Biopsy Market is expected to Double Its Size - openPR

Oct 11, 2024
pulisher
Oct 11, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 11, 2024
pulisher
Oct 09, 2024

NEO (Neogenomics Inc.) may reap gains as insiders became active recently - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Neogenomics Inc. (NEO)’s results reveal risk - US Post News

Oct 09, 2024
pulisher
Oct 08, 2024

Insider’s View: Deciphering Neogenomics Inc. (NEO)’s Financial Health Through Ratios - The Dwinnex

Oct 08, 2024
pulisher
Oct 08, 2024

Anatomic Pathology Market Is Expected To Grow Exponentially By The 2031 | Inc., Bio SB, Biogenex Laboratories, Danaher Corporation, F. Hoffmann-La Roche AG., Laboratory Corporation of America Holdings, Neogenomics Laboratories – Times-BD24 - Times-BD24

Oct 08, 2024
pulisher
Oct 08, 2024

NeoGenomics (NEO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Zacks Investment Research

Oct 08, 2024
pulisher
Oct 08, 2024

NeoGenomics Unveils AML Express - Baystreet.ca

Oct 08, 2024
pulisher
Oct 08, 2024

NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia - Business Wire

Oct 08, 2024
pulisher
Oct 07, 2024

Is Neogenomics Inc. (NEO) positioned for future growth? - SETE News

Oct 07, 2024
pulisher
Oct 03, 2024

Did Neogenomics Inc. (NEO) perform well in the last session? - US Post News

Oct 03, 2024
pulisher
Oct 03, 2024

Sei Investments Co. Has $3.66 Million Position in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

Oct 03, 2024
pulisher
Oct 03, 2024

Sei Investments Co. Boosts Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Oct 03, 2024
pulisher
Oct 02, 2024

Recent Insider Activity Suggests Potential Gains for Neogenomics Inc. (NEO) - Knox Daily

Oct 02, 2024
pulisher
Oct 01, 2024

NeoGenomics Becomes Oversold (NEO) - Nasdaq

Oct 01, 2024
pulisher
Oct 01, 2024

Point72 Asset Management L.P. Reduces Stock Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Oct 01, 2024
pulisher
Oct 01, 2024

NeoGenomics (NASDAQ:NEO) Stock Price Down 6.4% - Defense World

Oct 01, 2024
pulisher
Sep 30, 2024

Financial Fitness Check: Examining Neogenomics Inc. (NEO)’s Key Ratios - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

It is Poised to be a Bull Market for Neogenomics Inc. (NEO) - SETE News

Sep 30, 2024
pulisher
Sep 30, 2024

Public Employees Retirement Association of Colorado Decreases Holdings in NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

NeoGenomics, Inc. (NASDAQ:NEO) Shares Acquired by Dimensional Fund Advisors LP - MarketBeat

Sep 30, 2024
pulisher
Sep 27, 2024

FY2024 Earnings Estimate for NeoGenomics, Inc. Issued By William Blair (NASDAQ:NEO) - MarketBeat

Sep 27, 2024
pulisher
Sep 26, 2024

Brokers Offer Predictions for NeoGenomics, Inc.'s Q4 2025 Earnings (NASDAQ:NEO) - MarketBeat

Sep 26, 2024
pulisher
Sep 26, 2024

Cancer Tumor Profiling Market Company Profiles, Segments, - openPR

Sep 26, 2024
pulisher
Sep 26, 2024

Fred Alger Management LLC Sells 504,854 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - MarketBeat

Sep 26, 2024
pulisher
Sep 25, 2024

NeoGenomics (NASDAQ:NEO) Rating Reiterated by Needham & Company LLC - MarketBeat

Sep 25, 2024
pulisher
Sep 24, 2024

Benchmark maintains Buy rating on Neogenomics stock - Investing.com

Sep 24, 2024
pulisher
Sep 24, 2024

Neogen (NASDAQ:NEOG) Stock Price Down 4% - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Nasdaq Composite (NASX) QuotePress Release - The Globe and Mail

Sep 24, 2024
pulisher
Sep 24, 2024

First Light Asset Management LLC Acquires 480,396 Shares of NeoGenomics, Inc. (NASDAQ:NEO) - Defense World

Sep 24, 2024

Finanzdaten der Neogenomics Inc-Aktie (NEO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$226.42
price up icon 3.48%
diagnostics_research LH
$229.11
price up icon 0.85%
diagnostics_research WAT
$387.17
price down icon 0.04%
$154.96
price up icon 0.96%
diagnostics_research MTD
$1,385.79
price up icon 1.60%
$415.98
price up icon 0.35%
Kapitalisierung:     |  Volumen (24h):